You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Concordance between genotypic (MTBDRplus assay) and phenotypic (Buddemeyer assay) resistance

From: Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplusassay and their implication for treatment outcomes in patients from Mumbai, India

Sample INH RIF
  % Concordance kappa % Concordance kappa
Onset (n = 88) 86 0.72 94 0.84
5th month (n = 67) 97 0.74 99 0.85
Cumulative (n = 155) 91 0.80 96 0.92